___

• Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y et al. (2010). Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World Journal of Gastroenterology 16 (28): 3521-3528. doi: 10.3748/ wjgv16.i28.3521
• Archer KJ, Mas VR, Maluf DG, Fisher RA (2010). High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Molecular Genetics and Genomics 283 (4): 341-349. doi: 10.1007/s00438-010-0522-y
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal of Clinicians 68 (6): 394-424. doi: 10.3322/caac.21492
• Bublik DR, Bursać S, Sheffer M, Oršolić I, Shalit T et al. (2017). Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proceedings of the National Academy of Sciences of the United States of America 114 (4): E496-E505. doi: 10.1073/ pnas.1614876114
• Castillo DS, Campalans A, Belluscio LM, Carcagno AL, Radicella JP et al. (2015). E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells. Cell Cycle 14 (8): 1300-1314. doi: 10.4161/15384101.2014.985031
• Cavga AD, Tardu M, Korkmaz T, Keskin O, Ozturk N et al. (2019). Cryptochrome deletion in p53 mutant mice enhances apoptotic and anti-tumorigenic responses to UV damage at the transcriptome level. Functional & Integrative Genomics 19 (5): 729-742. doi: 10.1007/s10142-019-00680-5
• Chen B, Garmire L, Calvisi DF, Chua MS, Kelley RK et al. (2020). Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature reviews. Gastroenterology & Hepatology 17 (4): 238-251. doi: 10.1038/s41575-019-0240-9
• Chen L, Liu B (2017). Relationships between stress granules, oxidative stress, and neurodegenerative diseases. Oxidative Medicine and Cellular Longevity 2017: 1809592. doi: 10.1155/2017/1809592
• Coleman SJ, Grose RP, Kocher HM (2014). Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma. Journal of Hepatocellular Carcinoma 1: 43-54. doi: 10.2147/JHC.S48958
• de Peralta MS, Mouguelar VS, Sdrigotti MA, Ishiy FA, Fanganiello RD et al. (2016). Cnbp ameliorates Treacher Collins Syndrome craniofacial anomalies through a pathway that involves redoxresponsive genes. Cell Death and Disease 7 (10): e2397. doi: 10.1038/cddis.2016.299
• Di Maso V, Mediavilla MG, Vascotto C, Lupo F, Baccarani U et al. (2015). Transcriptional up-regulation of APE1/Ref-1 in hepatic tumor: role in hepatocytes resistance to oxidative stress and apoptosis, PLoS One 10 (12): e0143289. doi: 10.1371/journal. pone.0143289
• Edgar R, Domrachev M, Lash AE (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30 (1): 207-210.
• Engedal N, Žerovnik E, Rudov A, Galli F, Olivieri F et al. (2018). From oxidative stress damage to pathways, networks, and autophagy via MicroRNAs. Oxidative Medicine and Cellular Longevity 2018: 4968321. doi: 10.1155/2018/4968321
• Fulda S, Gorman AM, Hori O, Samali A (2010). Cellular stress responses: cell survival and cell death. International Journal of Cell Biology 2010: 214074. doi: 10.1155/2010/214074
• Galili T, O’Callaghan A, Sidi J, Sievert C (2017). heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics 34 (9): 1600-1602. doi: 10.1093/ bioinformatics/btx657
• Gu YT, Wang YC, Zhang HJ, Zhao TT, Sun SF (2017). Protective effect of dihydropteridine reductase against oxidative stress is abolished with A278C mutation. Journal of Zhejiang University. Science B 18 (9): 770-777. doi: 10.1631/jzusB1600123
• Guo M, Zhang H, Zheng J, Liu Y (2020). Glypican-3: a new target for diagnosis and treatment of hepatocellular carcinoma. Journal of Cancer 11 (8): 2008-2021. doi: 10.7150/jca.39972
• Halliwell B (2007). Oxidative stress and cancer: have we moved forward? The Biochemical Journal 401 (1): 1-11. doi: 10.1042/ BJ20061131
• Huang SS, Fraenkel E (2009). Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks. Science Signaling 2 (81): ra40. doi: 10.1126/scisignal.2000350
• Huang YL, Ning G, Chen LB, Lian YF, Gu YR et al. (2019). Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma. Cancer Management and Research 11: 1725-1740. doi: 10.2147/CMAR.S182001
• Ibrahim S, Li G, Hu F, Hou Z, Chen Q et al. (2018). PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway. Cancer Biology and Therapy 19 (3): 222-229. doi: 10.1080/15384047.2017.1416936
• Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T et al. (2003). Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 22 (19): 3007-3014. doi: 10.1038/sj.onc.1206401
• Irmak MB, Ince G, Ozturk M, Cetin-Atalay R (2003). Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Research 63: 6707-6715.
• Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C et al. (2009) STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Research D412-6. doi: 10.1093/nar/gkn760
• Jenkins E, Brenner M, Laragione T, Gulko PS (2012). Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10. Genes and Immunity 13 (3): 221-231. doi: 10.1038/gene.2011.73
• Jiang L, Wu CL, Wu JZ, Yang X, Wang HL et al. (2019). Microarraybased measurement of microRNA-449c-5p levels in hepatocellular carcinoma and bioinformatic analysis of potential signaling pathways. Pathology Research and Practice 215 (1): 68-81. doi: 10.1016/j.prp.2018.10.007
• Kiermayer C, Michalke B, Schmidt J, Brielmeier M (2007). Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice. Biological Chemistry 388 (10): 1091-1097. doi: 10.1515/BC.2007.133
• Kreyszig E (1979). Advanced Engineering Mathematics. 4th ed. Hoboken, NJ, USA: Wiley.
• Lee D, Xu IM, Chiu DK, Leibold J, Tse AP et al. (2019). Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma. Hepatology 69 (4): 1768-1786. doi: 10.1002/hep.30467
• Lee D, Xu IM, Chiu DK, Lai RK, Tse AP et al. (2017). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. The Journal of Clinical Investigation 127 (5): 1856-1872. doi: 10.1172/JCI90253
• Lian YF, Li SS, Huang YL, Wei H. Chen DM et al. (2018). Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma. Bioscience Reports 38 (6): BSR20181178. doi: 10.1042/BSR20181178
• Liu C, Wang R, Zhang Y (2019). GINS complex subunit 2 (GINS2) plays a protective role in alcohol-induced brain injury. Artificial Cells, Nanomedicine, and Biotechnology 47 (1): 1-9. doi: 10.1080/21691401.2018.1540425
• Liu H, Pathak P, Boehme S, Chiang JY (2016). Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. Journal of Lipid Research 57 (10): 1831-1844. doi: 10.1194/jlr.M069807
• Liyanage DS, Omeka WKM, Yang H, Godahewa GI, Kwon H et al. (2019). Identification of thioredoxin domain-containing protein 17 from big-belly seahorse Hippocampus abdominalis: Molecular insights, immune responses, and functional characterization. Fish & Shellfish Immunology 86: 301-310. doi: 10.1016/j.fsi.2018.11.040
• Menyhárt O, Nagy Á, Győrffy B (2018). Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. Royal Society Open Science 5 (12): 181006. doi: 10.1098/rsos.181006
• Migita T, Okabe S, Ikeda K, Igarashi S, Sugawara S et al. (2013). Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact. The American Journal of Pathology 182 (5): 1800-1810. doi: 10.1016/j.ajpath.2013.01.048
• Nwosu ZC, Megger DA, Hammad S, Sitek B, Roessler S et al. (2017). Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology, 4 (2): 303-323.e1. doi: 10.1016/j.jcmgh.2017.05.004.
• Nishida N, Chishina H, Arizumi T, Takita M, Kitai S et al. (2014). Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmasking. Digestive Diseases 32 (6): 740-746. doi: 10.1159/000368015
• Pantic B, Trevisan E, Citta A, Rigobello MP, Marin O et al. (2013). Myotonic dystrophy protein kinase (DMPK) prevents ROSinduced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface. Cell Death and Disease 4 (10): e858. doi: 10.1038/cddis.2013.385
• Papp LV, Lu J, Holmgren A, Khanna KK (2007). From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxidant and Redox Signaling 9 (7): 775-806. doi: 10.1089/ars.2007.1528
• Pope ED, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JA et al. (2019). Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opinion on Therapeutic Targets 23 (6): 473-483. doi: 10.1080/14728222.2019.1615883
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW et al. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43 (7): e47. doi: 10.1093/nar/gkv007
• Sarret C, Ashkavand Z, Paules E, Dorboz I, Pediaditakis P et al. (2019). Deleterious mutations in ALDH1L2 suggest a novel cause for neuro-ichthyotic syndrome. NPJ Genomic Medicine 4: 17. doi: 10.1038/s41525-019-0092-9
• Siegel R, Kimberly D, Jemal A et al. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians 70: 7-30. doi: 10.3322/ caac.21590
• Si M, Zhao C, Zhang B, Wei D, Chenet K et al. (2016). Overexpression of mycothiol disulfide reductase enhances corynebacterium glutamicum robustness by modulating cellular redox homeostasis and antioxidant proteins under oxidative stress. Scientific Reports 6: 29491. doi: 10.1038/srep29491
• Song L, Wei X, Zhang B, Luo X, Liu J et al. (2009). Role of Foxa1 in regulation of bcl2 expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes. Cell Stress Chaperones 14 (4): 417-425. doi: 10.1007/s12192-008-0095-4
• Strungaru MH, Footz T, Liu Y, Berry FB, Belleau P et al. (2011). PITX2 is involved in stress response in cultured human trabecular meshwork cells through regulation of SLC13A3. Investigative ophthalmology and visual science 52 (10): 7625- 7633. doi: 10.1167/iovs.10-6967
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102 (43): 15545-50. doi: 10.1073/ pnas.0506580102
• Takatori H, Yamashita T, Honda M, Nishino R, Arai K et al. (2010) dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma. Liver International 30 (3): 438-446. doi: 10.1111/j.1478-3231.2009.02177x
• Tan J, Duan M, Yadav T, Phoon L, Wang X et al. (2020). An R-loopinitiated CSB-RAD52-POLD3 pathway suppresses ROSinduced telomeric DNA breaks. Nucleic Acids Research 48 (3): 1285-1300. doi: 10.1093/nar/gkz1114
• Tuncbag N, Milani P, Pokorny JL, Johnson H, Sio TT et al. (2016). Network modeling identifies patient-specific pathways in glioblastoma. Scientific Reports 29 (6): 28668. doi: 10.1038/ srep28668
• Wang JH, Urrutia-Cabrera D, Mesa Mora S, Nguyen T, Hung S et al. (2020). Functional study of the AMD-associated gene TMEM97 in retinal pigmented epithelium using CRISPR interference. BioRxiv. doi: 10.1101/2020.07.10.198143
• Waris G, Ahsan, H. (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. Journal of Carcinogenesis 5: 14. doi: 10.1186/1477-3163-5-14
• Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M (2007) The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Computational Biology 3: e59. doi: 10.1371/journal. pcbi.0030059
• Yu GI, Mun KH, Yang SH, Shin DH, Hwang JS (2018). Polymorphisms in the 3’-UTR of SCD5 gene are associated with hepatocellular carcinoma in Korean population. Molecular Biology Reports 45 (6): 1705-1714. doi: 10.1007/s11033-018-4313-6
• Zamorano J, Wang HY, Wang R, Shi Y, Longmore GD et al. (1998). Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. The Journal of Immunology 160 (7): 3502-3512.
• Zhang H, Dong Y, Zhao H, Brooks JD, Hawthorn L et al. (2005). Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. Cancer Genomics Proteomics 2 (2): 97-114.
• Zhou J, Chng WJ (2013). Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis, and cancer. Mitochondrion 13 (3): 163-169.